Search research articles
Contact Us
Filters
Showing results (31-40 of 159) with videos related to
Page
of 16
Sort By:
Journal of Occupational and Environmental Medicine
|
February 25, 2011
A business case evaluation of workplace engineering noise control: a net-cost model
Supriya Lahiri, Colleen Low, Michael Barry
Pharmacoeconomics
|
June 7, 2012
Value-of-information analysis to reduce decision uncertainty associated with the choice of thromboprophylaxis after total hip replacement in the Irish healthcare setting
Laura McCullagh, Cathal Walsh, Michael Barry
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
September 29, 2004
Pricing and reimbursement of drugs in Ireland
Michael Barry, Lesley Tilson, Máirín Ryan
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
June 25, 2005
The potential impact of implementing a system of generic substitution on the community drug schemes in Ireland
Lesley Tilson, Kathleen Bennett, Michael Barry
The Journal of the Acoustical Society of America
|
July 24, 2010
Dynamics of temporal variations in phonatory flow
Michael H Krane, Michael Barry, Timothy Wei
Pharmacoeconomics - Open
|
May 11, 2019
Analysis of Health Technology Assessments of Orphan Drugs in Ireland from 2012 to 2017
Cara Usher, Laura McCullagh, Lesley Tilson, et al.
Clinical Therapeutics
|
March 3, 2012
Cost containment interventions introduced on the community drugs schemes in Ireland-evaluation of expenditure trends using a national prescription claims database
Cara Usher, Lesley Tilson, Kathleen Bennett, et al.
Fertility and Sterility
|
January 15, 2008
Power Doppler assessment of follicle vascularity at the time of oocyte retrieval in in vitro fertilization cycles
Stephen J Robson, Michael Barry, Robert J Norman
Pharmacoeconomics
|
October 7, 2009
A cost-effectiveness model comparing rivaroxaban and dabigatran etexilate with enoxaparin sodium as thromboprophylaxis after total hip and total knee replacement in the irish healthcare setting
Laura McCullagh, Lesley Tilson, Cathal Walsh, et al.
British Journal of Clinical Pharmacology
|
May 30, 2020
Sacubitril/valsartan (Entresto) utilisation and prescribing patterns in the context of a reimbursement application system
Cormac Kennedy, Amelia Smith, Stephen Doran, et al.
Page
of 16
Search research articles
Search
Showing results (31-40 of 159) with videos related to
Sort By:
Page
of 16
Journal of Occupational and Environmental Medicine
|
February 25, 2011
A business case evaluation of workplace engineering noise control: a net-cost model
Supriya Lahiri, Colleen Low, Michael Barry
Pharmacoeconomics
|
June 7, 2012
Value-of-information analysis to reduce decision uncertainty associated with the choice of thromboprophylaxis after total hip replacement in the Irish healthcare setting
Laura McCullagh, Cathal Walsh, Michael Barry
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
September 29, 2004
Pricing and reimbursement of drugs in Ireland
Michael Barry, Lesley Tilson, Máirín Ryan
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
June 25, 2005
The potential impact of implementing a system of generic substitution on the community drug schemes in Ireland
Lesley Tilson, Kathleen Bennett, Michael Barry
The Journal of the Acoustical Society of America
|
July 24, 2010
Dynamics of temporal variations in phonatory flow
Michael H Krane, Michael Barry, Timothy Wei
Pharmacoeconomics - Open
|
May 11, 2019
Analysis of Health Technology Assessments of Orphan Drugs in Ireland from 2012 to 2017
Cara Usher, Laura McCullagh, Lesley Tilson, et al.
Clinical Therapeutics
|
March 3, 2012
Cost containment interventions introduced on the community drugs schemes in Ireland-evaluation of expenditure trends using a national prescription claims database
Cara Usher, Lesley Tilson, Kathleen Bennett, et al.
Fertility and Sterility
|
January 15, 2008
Power Doppler assessment of follicle vascularity at the time of oocyte retrieval in in vitro fertilization cycles
Stephen J Robson, Michael Barry, Robert J Norman
Pharmacoeconomics
|
October 7, 2009
A cost-effectiveness model comparing rivaroxaban and dabigatran etexilate with enoxaparin sodium as thromboprophylaxis after total hip and total knee replacement in the irish healthcare setting
Laura McCullagh, Lesley Tilson, Cathal Walsh, et al.
British Journal of Clinical Pharmacology
|
May 30, 2020
Sacubitril/valsartan (Entresto) utilisation and prescribing patterns in the context of a reimbursement application system
Cormac Kennedy, Amelia Smith, Stephen Doran, et al.
Page
of 16